The upcoming week is set to be a major test for the primary markets, with 20 companies preparing for public debuts across both mainboard and SME segments. Market participants are closely watching these launches as liquidity remains high.
Early indicators from the grey market show significant investor appetite. Analysts noted that standout prospects like Symbiotec Pharmalab, Tempsens Instruments, and Lumino Industries are currently commanding the strongest premiums among the cohort.
Expected Performance Breakdown:
- High-demand issues signaling potential listing gains between 50% and 100%.
- A mix of fresh capital raises and existing shareholder exits.
- Increased volatility expected in the SME category due to lower float sizes.
While the grey market data provides a glimpse into sentiment, investors are advised to exercise caution. High premiums often fluctuate rapidly in the lead-up to the official listing date based on changing macroeconomic conditions.
